Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2005-10-20
2009-12-29
Haq, Shafiqul (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007100, C435S007900, C436S533000, C436S535000, C436S544000, C436S546000, C436S815000, C530S403000, C530S406000, C530S388900, C530S389800, C549S200000
Reexamination Certificate
active
07638291
ABSTRACT:
Generally, the present invention relates to topiramate analogs that have substituents at the sulfamate group or at the 9-position or 10-position. The topiramate analogs can include immunogenic moieties that can be used to prepare anti-topiramate antibodies, or antigenic moieties that can be used in immunodiagnostic assays for topiramate. Also, the topiramate analog can include tracer moieties for detecting the presence or amount of the analog during an immunodiagnostic assay. Additionally, the topiramate analogs can be used in immunodiagnostic assays to compete with topiramate for binding with anti-topiramate antibodies.
REFERENCES:
patent: 4492762 (1985-01-01), Wang et al.
patent: 4593089 (1986-06-01), Wang et al.
patent: 4668640 (1987-05-01), Wang et al.
patent: 4708929 (1987-11-01), Henderson
patent: 4751190 (1988-06-01), Chiapetta et al.
patent: 4847209 (1989-07-01), Lewis et al.
patent: 5120653 (1992-06-01), Henderson
patent: 5571728 (1996-11-01), Kraus
patent: 5604091 (1997-02-01), Henderson
patent: 5643734 (1997-07-01), Henderson
patent: 5798083 (1998-08-01), Massey et al.
patent: 5834206 (1998-11-01), Neuenhofer et al.
patent: 5952187 (1999-09-01), Stenglein et al.
patent: 6248597 (2001-06-01), Eda et al.
patent: 6448091 (2002-09-01), Massey et al.
patent: 6514770 (2003-02-01), Sorin
patent: 6699840 (2004-03-01), Almarsson et al.
patent: 7060725 (2006-06-01), Abdel-Magid et al.
patent: 7098188 (2006-08-01), Abdel-Magid et al.
patent: 7157589 (2007-01-01), Berkner et al.
patent: 2004/0258758 (2004-12-01), Gustow et al.
patent: WO 2006/047204 (2000-05-01), None
patent: WO 2006/047450 (2006-05-01), None
Faivre-Chauvet et al. Introduction of five potentially metabolizable linking groups between in-cyclohexyl EDTA derivatives and F(ab')2 fragments of anti-carcinoembryonic antigen antibody-II. Comparative pharmacokinetics and biodistribution in Human colorectal carcinoma-bearing nude mice. Nucl. Med. Biol 1993, vol. 20, No. 6, pp. 763-771.
Christensen, Jakob, et al.; “Liquid Chromatography Tandem Mass Spectrometry Assay for Topiramate Analysis in Plasma and Cerebrospinal Fluid: Validation and Comparison with Fluorescence-Polarization Immunoassay,”Therapeutic Drug Monitoring, 24:658-665; received Nov. 14, 2001; accepted Mar. 27, 2002.
Berry, David J., et al.; “Comparison of Topiramate Concentrations in Plasma and Serum by Fluorescence Polarization Immunoassay,”Therapeutic Drug Monitoring, 22:460-464; received Aug. 2, 1999, accepted Feb. 29, 2000.
Chen, Su, et al.; “Validation of liquid-liquid extraction followed by flow-injection negative ion electrospray mass spectrometry assay to Topiramate in human plasma,”Rapid Communications in Mass Spectrometry, 2001; 15:159;163.
Tang, Peter H., et al.; “An Improved Gas Chromatography Assay for Topiramate Monitoring in Pediatric Patients,”Therapeutic Drug Monitoring, 22:195-201; received Feb. 23, 1999; accepted Sep. 30, 1999.
Mozayani, Ashraf, et al.; “Distribution of Topiramate in a Medical Examiner's Case,”Journal of Analytical Toxicology, vol. 23, Oct. 1999.
Riffitts, J.M., et al.; “A capillary gas chromatographic assay with nitrogen phosphorus detection for the quantification of topiramate in human plasma, urine and whole blood,”Journal of Pharmaceutical and Biomedical Analysis, 19 (1999) 363-371; received Nov. 8, 1996; accepted May 8, 1998.
Holland, Mary L., et al.; “Automated capillary gas chromatographic assay using flame ionization detection for the determination of topiramate in plasma,”Journal of Chromatography, 433 (1988) 276-281; first received May 16, 1988; revised manuscript received Aug. 1, 1988.
Maryanoff, et al., “Anticonvulsant O-Alkyl Sulfamates. 2,3:4,5-Bis-O-(1-methylethylidend)-β-D-fructopyranose Sulfamate and Related Compounds,”J. Med. Chem. (1987), 30, 880-887.
U.S. Appl. No. 11/254,598, filed Oct. 20, 2005, Ouyang et al.
U.S. Appl. No. 11,858,426, filed Sep. 20, 2007, Ouyang et al.
International Preliminary Report on Patentability, from PCT/US2005/037698, May 1, 2007, 5 pages.
Written Opinion, from PCT/US2005/037698, Feb. 17, 2006, 4 pages.
International Search Report, from PCT/US2005/037698, Mar. 14, 2006, 2 pages.
International Preliminary Report on Patentability, from PCT/US2005/038257, May 1, 2007, 6 pages.
Written Opinion, from PCT/US2005/038257, May 23, 2006, 5 pages.
International Search Report, from PCT/US2005/038257, Aug. 4, 2006, 2 pages.
Office Action dated Apr. 4, 2008, from U.S. Appl. No. 11/254,598, 10 pages.
Arabshahi Lili
Ouyang Anlong
Haq Shafiqul
Seradyn, Inc.
Workman Nydegger
LandOfFree
Immunoassays for topiramate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunoassays for topiramate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunoassays for topiramate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4064923